Who we are

We are a health data and insights business focused on metabolic disease.

Our Vision

Empower every person to understand and improve their health.

Our Mission

To build the world’s most comprehensive, rich metabolic data set enabling earlier identification and earlier intervention.

Our Values

Group 1092

Community

We create a supportive and harmonious work environment by being open, patient and celebrating each
other.

Group 132

Making a Difference

Being part of positive change in the world is what drives us. Do your best for the patient, listen and measure our impact.

Group 1093

Commitment

We are dedicated to delivering our best work in the right way. Our team welcomes commitment in its healthiest form allowing wellbeing to be a priority.

Group 1096

Excellence

We stay informed and always strive to improve and create work we can be proud of. Delivering tangible results that reflect the outstanding talent of our team.

Group 1095

Inspiration

Seek opportunities and motivation to create momentum and enjoyment. 

Ask questions and stay curious.

Group 1094

Respect

Consideration and respect for others and our resources allow us to build a culture of honesty and trust.

We are a dynamic team of experts, thought leaders and innovators; all motivated by the common goal to improve lives.

Our JOURNEY

Gendius

We began our journey in 2015 on a mission to improve the lives of those living with diabetes, since then, we have expanded our reach and expertise to allow us to offer real solutions to problems faced by patients and healthcare professsionals.

2015

Gendius formed

2018

Gestational Diabetes Mellitus research completed
2018

intellin goes live

The app and healthcare professional dashboard provide connected care for diabetic patients
2020

AstraZeneca partnership

2021

University of Nottingham partnership

2021

University of Manchester partnership

2021

Data Science team expanded

2022

HealthGate launched

Technology for diabetes risk prediction launched in the GCC through the new AstraZeneca patient support app, HealthGate
2022

First CSP publication

CKD Screening Prioritizer work publication goes live
2022

CSP presented at EASD

Validation work for the CKD Screening Prioritizer is presented at EASD
2023

CSP goes live

with over 100,000 patients screened, in the first 4 months
2023

Health Innovation Accelerator started

Funded by the Innovate grant, our partnership with Health Innovation Manchester uses the CSP to help access underserved populations